The latest Clinical Network news and events

Friday 7 November, 2014

Medical cannabis

In response to recent national and state discussion in the media and political parties, we have developed a position statement on medical cannabis in cancer care

CCV’s election platform update

In recent months our CEO Todd Harper and representatives from CCV Board, Clinical Network Executive (Miss Orla McNally), and Medical & Scientific Committee met with the Liberal, Labour and Greens political parties to present Cancer Council Victoria’s priorities for the state election.

Meetings included current Health Minister, and the Opposition Leader and shadow Health Minister.  The meetings were very positive, with follow up conversations with all three parties to keep them informed of CCV priorities.  This advocacy work has been supported by public engagement campaigns. Continued advocacy will focus on political advisors to the major parties.

Refinement of the standard list of items associated with conducting Clinical Trials in Australia

The results of the refinement of the list of standard clinical trial items developed last year conducted by Health Consult on behalf of NHMRC have been released, with a call for feedback on section 3 of the report.  The Clinical Research Professionals Committee developed a response to this call for comments, noting the change in emphasis from costing items to costing activities associated with clinical trial conduct, which is considered a shortcoming. For a copy of the submission please contact clincal.network@cancervic.org.au  

Call for better protection at work from cancer

Cancer Council Victoria today welcomed a commitment from both the Victorian Liberal Government and Labor State Opposition to introduce new laws that will make it easier for career and volunteer firefighters with cancer to get compensation. However, the evidence shows more needs to be done to prevent occupational cancers, which, based on latest estimates may account for between 2 and 5 per cent of all cancer cases in Australia.
Read the position statement in full here.

Long standing Clinical Network member A/Prof Ray Snyder retiring

Ray has dedicated 37 years to medical oncology at St Vincent’s Hospital. He joined VCOG when it was established in 1976 and has been a loyal member, leader and mentor since then. Throughout this time Ray has provided clinical direction through several leadership roles including chairing the Clinical Network, Breast Cancer Committee, Breast Trials Committee and Psycho-Oncology Committee. Ray’s dedication to CCV can be further seen through his current appointments on the CCV Council and the Standing Subcommittee on Research. Ray was also heavily involved with the Victorian Breast Cancer Research Consortium managed by the Cancer Council. Throughout the years Ray has been a champion of supporting clinical trials research in Victoria leading to a number of long-term initiatives here at CCV.

World Cancer Congress Dec 4-6 in Melbourne

The Clinical Network are presenting posters at the World Cancer Congress relating to:

  • The views of oncology professionals regarding the Victorian Cancer Trials Link (VCTL), an online clinical trials portal
    (Authors: Cat Parker, A/Prof Michael Jefford, A/Prof Jeremy Millar)
  • An exploration of the relationship between funding and patient accrual to oncology clinical trials:  Additional Funding Intervention Trial (AFIT)
    (Authors: A/Prof Jeremy Millar, Cat Parker, A/Prof Ray Snyder)
  • Making the law work better for people affected by cancer
    (Authors: Danielle Spence, Nicola Quin, Esther Sadek, Rachel Whiffen, A/Prof Michael Jefford, Sondra Davoren, Dr Deborah Lawson, Sue Merritt). This relates to CCV’s Strategy and Support Division’s (encompassing Clinical Network) collaboration with the McCabe Centre for Law and Cancer to progress advocacy efforts to improve the Victorian Patient Travel Assistance Scheme (VPTAS).

The COSA ASM December 2-4 workshops and forums

 

Treatment as a form of liver cancer prevention: The clinical efficacy and cost effectiveness of treatment

Prof Henry Chan

Professor in the Department of Medicine and Therapeutics, Director of Chen Suen Man Shook Centre for Hepatitis Research and Director of the Centre for Liver Health of the Chinese University of Hong Kong.

We are delighted to have Professor Chan join us for a special presentation as part of his appointment with the World Cancer Congress.

Cancer Council Victoria, 4th December, 6.30pm-8.00pm.  An invitation will be circulated in the coming weeks. 

Integrated Cancer Services State-wide Lung Cancer Summit: improving lung cancer care in Victoria

The lung summit is a clinician-led forum for reviewing data about diagnosis, treatment and system factors impacting care of lung cancer patients in Victoria. This is the second of a series of tumour specific summit meetings hosted collaboratively by Victoria’s Integrated Cancer Services and Cancer Council Victoria.

Discussion topics include:

  • Delays in diagnosis
  • Multidisciplinary approach to treatment 
  • Referral pathways to specialist care
  • Proportion of patients receiving active treatment for lung cancer
  • Access to palliative and supportive care

Friday 14 November, RACV Club, 501 Bourke Street, Melbourne. Register here.